Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aztiq is an Iceland-based healthcare investment company and long-term fund focused on pharmaceutical and biotechnology businesses. Led by founder and chairman Róbert Wessman, the firm combines capital with operating expertise and invests in companies across the pharma value chain rather than functioning as a single-asset drug developer. Its portfolio and historical activities have included generics, biosimilars, and pharmaceutical commercialization businesses such as Alvotech, Lotus, and Adalvo. Aztiq positions itself as an active healthcare investor that helps management teams accelerate growth, improve operations, and expand access to medicines globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aztiq Group.